54.66MMarket Cap-284P/E (TTM)
3.314High3.150Low203.41KVolume3.250Open3.300Pre Close656.51KTurnover1.33%Turnover RatioLossP/E (Static)16.92MShares57.20052wk High0.23P/B49.30MFloat Cap3.15052wk Low--Dividend TTM15.26MShs Float57.200Historical High--Div YieldTTM4.97%Amplitude3.150Historical Low3.227Avg Price1Lot Size
Mural Oncology Stock Forum
NEWS
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
Mural Oncology presented data from its ARTISTRY-3 trial at the ASCO annual meeting, showing that less frequent dosing of nemvaleukin alfa (nemvaleukin), an engineered IL-2 cytokine, is well-tolerated and effective.
The trial shifted from five daily infusions to two infusions per three-week cycle, both as a single agent and in combination with pembrolizu...
NEWS
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
👃
👄
$Mural Oncology(MURA.US)$
No comment yet